AI app aims to tame epilepsy in remote villages

NCT ID NCT07448233

ENROLLING_BY_INVITATION Disease control Sponsor: Xijing Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an AI-powered health management system, accessed through a WeChat mini-program, can help adults with epilepsy in rural China have fewer seizures and better manage their condition. About 756 patients from eight rural counties will use the app for one year, and their results will be compared to those receiving standard care. The app includes features like AI consultations, medication reminders, and online doctor visits to support long-term epilepsy control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Neurology, Xijing Hospital, Air Force Medical University

    Xi'an, Shaanxi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.